Document Detail


Test-bolus injection for optimization of arterial phase imaging during contrast-enhanced hepatic MR imaging.
MedLine Citation:
PMID:  10992807     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Contrast enhancement during the dynamic MR imaging is important for the detection and characterization of focal liver lesions. The purpose of this study was to determine whether or not a timing examination with a injection of a 1.0-mL bolus of gadopentetate dimeglumine into the antecubital vein followed by rapid dynamic scanning and measurement of signal intensity of the aorta could help to obtain proper arterial-dominant phase images for the characterization of focal hepatic lesions during subsequent multiphase dynamic MR imaging. The imaging delay to acquisition of the first gadolinium-enhanced image for multiphase dynamic MR imaging was set to equal the time to peak aortic enhancement during the test examination. The first contrast-enhanced images of 80 patients with 160 focal liver lesions (hepatocellular carcinoma, n = 79; cavernous hemangioma, n = 51; metastatic tumor, n = 30) were then retrospectively reviewed. Peak aortic enhancement occurred between 10 and 28 seconds (mean, 16.5 seconds +/- 3.1) after starting the infusion of contrast material in 80 patients during the test-examination. Depending on the findings of intrahepatic vascular enhancement on the full-scale dynamic images, hepatic arterial phase (n = 11, 14%) or sinusoid phase (n = 65, 81%) imaging was obtained during the first gadolinium-enhanced acquisition in 76 (95%) of 80 patients. Three different lesions were well characterized and easily distinguished from each other (p < .0001) on the first-phase images depending on their enhancement pattern. In the majority of patients, timing examination with test-bolus injection was helpful in obtaining qualified images for the characterization of various focal lesions.
Authors:
J S Yu; K W Kim; B J Jo; M G Jeong; J K Kim; J K Hahm; J T Lee; H S Yoo
Related Documents :
10699307 - Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharma...
19864527 - Ductal carcinoma in situ: x-ray fluorescence microscopy and dynamic contrast-enhanced m...
11471617 - Comparison of dynamic contrast-enhanced mri with who tumor grading for gliomas.
9059417 - Functioning islet cell tumor of the pancreas. localization with dynamic spiral ct.
3118237 - Myelopathy due to diffuse thickening of the cervical dura mater in maroteaux-lamy syndr...
1626287 - The use of intravenous gadopentetate dimeglumine in magnetic resonance imaging of synov...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Yonsei medical journal     Volume:  41     ISSN:  0513-5796     ISO Abbreviation:  Yonsei Med. J.     Publication Date:  2000 Aug 
Date Detail:
Created Date:  2000-09-28     Completed Date:  2000-09-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0414003     Medline TA:  Yonsei Med J     Country:  KOREA (SOUTH)    
Other Details:
Languages:  eng     Pagination:  459-67     Citation Subset:  IM    
Affiliation:
Department of Diagnostic Radiology, Yonsei University College of Medicine, Seoul, Korea. yjsrad97@yumc.yonsei.ac.kr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Female
Hepatic Artery / pathology
Humans
Image Enhancement*
Liver / pathology*
Liver Neoplasms / diagnosis,  secondary
Magnetic Resonance Imaging
Male
Middle Aged
Time Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inter-relationships between arteriosclerotic risk factors: a meta-analysis.
Next Document:  A bone replaceable artificial bone substitute: morphological and physiochemical characterizations.